These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17214739)

  • 21. Management of acquired aplastic anemia in children.
    Korthof ET; Békássy AN; Hussein AA
    Bone Marrow Transplant; 2013 Feb; 48(2):191-5. PubMed ID: 23292240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal haemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anaemia.
    Yoshida N; Yagasaki H; Takahashi Y; Yamamoto T; Liang J; Wang Y; Tanaka M; Hama A; Nishio N; Kobayashi R; Hotta N; Asami K; Kikuta A; Fukushima T; Hirano N; Kojima S
    Br J Haematol; 2008 Jul; 142(3):427-35. PubMed ID: 18537977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful unmanipulated stem cell transplantation from HLA-haploidentical 3-loci-mismatched parents in two children with severe aplastic anemia not responding to immunosuppressive therapy.
    Wang Z; Yan H; Zhu L; Wang H
    Am J Hematol; 2010 May; 85(5):389-90. PubMed ID: 20425804
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppressive therapy without hematopoietic growth factor exposure in pediatric acquired aplastic anemia.
    Deyell RJ; Shereck EB; Milner RA; Schultz KR
    Pediatr Hematol Oncol; 2011 Sep; 28(6):469-78. PubMed ID: 21707222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO).
    Jeong DC; Chung NG; Kang HJ; Koo HH; Kook H; Kim SK; Kim SY; Kim HS; Kim HM; Park KD; Park SK; Park JS; Park JE; Park HJ; Park YS; Seo JJ; Sung KW; Shin HY; Ahn HS; Ryu KH; Ryu KH; Yoo ES; Lyu CJ; Lee KS; Lee KC; Lee SY; Lee YH; Lim YT; Lim YJ; Jung HL; Cho B; Choi YM; Hah JO; Hwang TJ; Kim HK
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):172-8. PubMed ID: 21325968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Okuda S; Terasako K; Oshima K; Sato M; Nakasone H; Kako S; Yamazaki R; Tanaka Y; Tanihara A; Higuchi T; Nishida J; Kanda Y
    Am J Hematol; 2009 Mar; 84(3):167-9. PubMed ID: 19195036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution in the management of acute liver failure-associated aplastic anaemia in children: a single centre experience.
    Hadzić N; Height S; Ball S; Rela M; Heaton ND; Veys P; Mieli-Vergani G
    J Hepatol; 2008 Jan; 48(1):68-73. PubMed ID: 17998144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
    Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L
    Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.
    Georges GE; Doney K; Storb R
    Blood Adv; 2018 Aug; 2(15):2020-2028. PubMed ID: 30108110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The A-B-C of haematopoietic stem cell transplantation.
    Rafeah NT; Fadilah SA
    Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP).
    Barone A; Lucarelli A; Onofrillo D; Verzegnassi F; Bonanomi S; Cesaro S; Fioredda F; Iori AP; Ladogana S; Locasciulli A; Longoni D; Lanciotti M; Macaluso A; Mandaglio R; Marra N; Martire B; Maruzzi M; Menna G; Notarangelo LD; Palazzi G; Pillon M; Ramenghi U; Russo G; Svahn J; Timeus F; Tucci F; Cugno C; Zecca M; Farruggia P; Dufour C; Saracco P;
    Blood Cells Mol Dis; 2015 Jun; 55(1):40-7. PubMed ID: 25976466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
    Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment strategies for patients with severe aplastic anemia.
    Bacigalupo A
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S42-S44. PubMed ID: 18724299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
    Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
    Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haematopoietic stem cell transplantation for acquired aplastic anaemia.
    Young ME; Potter V; Kulasekararaj AG; Mufti GJ; Marsh JC
    Curr Opin Hematol; 2013 Nov; 20(6):515-20. PubMed ID: 24104412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.